自主與成就

百靈佳殷格翰是一家擁有多元文化與社群的全球性企業。了解更多關於財務表現、企業願景、組織架構以及公司歷史以及我們在科學、文化和環境方面的參與。

A successful and independent Corporation

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.


關於百靈佳殷格翰

百靈佳殷格翰是全球前20大領先的製藥公司之一，總部位於德國殷格翰，在全球總計約有50,000名員工。百靈佳殷格翰成立於1885年，是全球最大的製藥家族企業，並專注於研發、製造和銷售對人類與動物健康方面高治療價值的新藥物與疫苗。台灣百靈佳殷格翰股份有限公司是百靈佳殷格翰在台子公司，成立於1975年，迄今已逾40年，目前在台灣北中南共設有5個辦公室，員工近300人。人類處方用藥及動物用藥是公司的核心業務，持續在呼吸道疾病、癌症、糖尿病、心血管疾病、帕金森氏症、HIV等領域幫助更多病患；近年，更是台灣成長最快速的藥廠。

百靈佳殷格翰公司始終承諾擔負社會責任，包括在全球參與的“ Making more Health 開創健康”社會服務平台與諸多員工關懷計畫，同時亦持續專注於環境保護和人類永續發展。文化上，以強調尊重，機會平等和工作與家庭/個人生活之平衡...等面向來形成企業內相互合作的基礎。

2015年，全球營業額為148億歐元，並投入淨銷售額的20.3%來研發更多幫助健康的藥物與疫苗。

更多社會責任行動，請造訪台灣百靈佳殷格翰社會服務平台
https://www.facebook.com/1975BITW/

Our Company

The Boehringer Ingelheim group is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, Boehringer Ingelheim operates globally with 146 affiliates and a total of more than 47,700 employees. The focus of the family-owned company, founded in 1885, is researching, developing, manufacturing and marketing new medications of high therapeutic value for human and veterinary medicine.

Social responsibility is an important element of the corporate culture at Boehringer Ingelheim. This includes worldwide involvement in social projects, such as the initiative “Making more Health” and caring for the employees. Respect, equal opportunities and reconciling career and family form the foundation of the mutual cooperation. In everything it does, the company focuses on environmental protection and sustainability.

In 2014, Boehringer Ingelheim achieved net sales of about 13.3 billion euros. R&D expenditure corresponds to 19.9 per cent of its net sales.

More CSR information:
https://www.facebook.com/1975BITW/